Bitbrain develops neurotechnology solutions for brain and body monitoring, including hardware and software tools for data collection and analysis in various scientific applications. The company is self-described as user-friendly and reliable.

Bitbrain

BrainCo develops brain-machine interface technologies aimed at enhancing possibilities in rehabilitation, health, and education.

BrainCo

MetaBrain is a large scale eQTL meta-analysis of previously published human brain eQTL datasets, providing a browser for cis-eQTL and trans-eQTL meta-analysis in Cortex samples from European ancestry, as well as a gene network for annotating genes and performing gene set enrichment analyses.

MetaBrain

Advertising Services

usenns

Bitbrain | 13,199 followers on LinkedIn. High-tech EEG brain sensing devices &amp; software solutions for human behaviour research, health and neurotech development. | Bitbrain was founded in 2010 as a spin-off company of a research team  from the University of Zaragoza, pioneer in approaching brain-computer  interface applications outside laboratory investigation settings. 
Its DNA holds all knowledge in neurotechnology, biomedical engineering, artificial intelligence and data science accumulated at the university  since 1998. 
Nowadays, the R+D+I bet is still strong, which has converted the company in a world reference for B2B neurotechnology solutions.

Agile Analyst-Engineer with strong expertise in Data and Software development

Stefan Kennis

Lecturer at HWZ & SIW

Gökhan Altinok

Co-Founder and CEO Bitbrain

Maria Lopez Valdes, PhD.

PhD in robotics

Pablo Urcola

🔍 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗡𝗲𝘂𝗿𝗼𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀: 𝗣𝗼𝗿𝘁𝗮𝗯𝗹𝗲 𝗘𝗘𝗚 𝗮𝗻𝗱 𝗔𝗜 𝗳𝗼𝗿 𝗘𝗮𝗿𝗹𝘆 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗦𝗶𝗴𝗻𝘀 As part of the scientific community, we want to share some interesting data and results regarding one of our products that was used in a study that evaluates the potential of using a self-driven, fully automated EEG-based approach to diagnose Alzheimer's Disease (AD) at early stages. The Versatile EEG 16 is emphasized as a 𝗽𝗼𝗿𝘁𝗮𝗯𝗹𝗲, 𝗿𝗲𝗹𝗶𝗮𝗯𝗹𝗲 𝗮𝗻𝗱 𝗲𝗮𝘀𝘆-𝘁𝗼-𝘂𝘀𝗲 𝗶𝗻𝘀𝘁𝗿𝘂𝗺𝗲𝗻𝘁, which makes it perfect for early Alzheimer's detection in clinical and research settings. Have a look at the technical specifications here: https://lnkd.in/dpmZsnvH The study aimed to investigate how three groups: Mild Cognitive Impairment (MCI-non-AD), mild AD, and healthy controls could be categorized using a commercial EEG system, the 𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗲 𝗘𝗘𝗚 𝟭𝟲, based on their brainwave signals during resting state activity. To achieve this, the research team used a multi-step classification pipeline that included feature extraction, artifact rejection, and machine learning approaches (MLP classifier). The system achieved 𝟵𝟱% 𝘀𝘂𝗯𝗷𝗲𝗰𝘁-𝗹𝗲𝘃𝗲𝗹 𝗮𝗰𝗰𝘂𝗿𝗮𝗰𝘆, successfully identifying both 𝗠𝗖𝗜-𝗻𝗼𝗻-𝗔𝗗 and 𝗺𝗶𝗹𝗱 𝗔𝗗 groups with high precision. Read the full article here: https://lnkd.in/dNNsMMbp Congratulations to Universidad de Granada and all the researchers Eduardo Pérez-Valero , Miguel Ángel Lopez-Gordo, Christian Morillas Gutiérrez, Ismael Carrera-Muñoz y Rosa M. Vílchez-Carrillo. It is evident from the results that this method holds promise for the field of neurodiagnostic in the future. #EEG #MedicalInnovation #MachineLearning #Neurodiagnostics #neurotecnology #Alzheimer

𝗙𝗶𝗻𝗮𝗹 𝗱𝗮𝘆 𝗮𝘁 𝗠𝗘𝗗𝗜𝗖𝗔 𝟮𝟬𝟮𝟰! Today marks the end of an inspiring week at MEDICA - Leading International Trade Fair . We had the opportunity of showcasing our innovative 𝗛𝗼𝗺𝗲𝗟𝗮𝗯, and end-to-end solution for EEG and Sleep-EEG at home. The solution features advanced textile-EEG sensors and artificial intelligence tools for automated EEG and sleep scoring. We’re working toward 𝗖𝗘 𝗮𝗻𝗱 𝗙𝗗𝗔 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲, 𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗶𝗻 𝟮𝟬𝟮𝟱, with a 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘃𝗲𝗿𝘀𝗶𝗼𝗻 𝗽𝗹𝗮𝗻𝗻𝗲𝗱 𝗳𝗼𝗿 𝗿𝗲𝗹𝗲𝗮𝘀𝗲 𝗲𝗮𝗿𝗹𝘆 𝟮𝟬𝟮𝟱. This will allow patients to access clinical-grade diagnostics from the comfort of their homes. We extend our thanks to everyone who visited our booth and invite those interested in learning more to explore our website: https://lnkd.in/djxYNxRZ #EEG #Research #MedicalTechnology #FutureOfMedicine #MedTech

The 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗠𝘂𝗹𝘁𝗶-𝗕𝗿𝗮𝗶𝗻 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟰 organised by the Institute of Neurosciences of the University of Barcelona brings together experts from diverse fields of neuroscience to explore the complexities of the human brain and we are proud to be part of it. Being part of this pioneering congress for the second time is exciting, as the latest discoveries in the 𝘀𝘁𝘂𝗱𝘆 𝗼𝗳 𝘁𝗵𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝘆, 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹, 𝗮𝗻𝗱 𝗮𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗯𝗿𝗮𝗶𝗻 will be discussed. Our focus on 𝗻𝗲𝘂𝗿𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 aligns perfectly with the congress’s vision: advancing brain science through collaboration and the application of new technologies. We are working to bridge the gap between research and clinical practice, developing wearable EEG devices that monitor 𝗯𝗿𝗮𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵 and improve cognitive function in the lab and real-world environments. 𝗢𝗻 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆, 𝘁𝗵𝗲 𝟭𝟰𝘁𝗵, our expert Esperanza will present a Flash Talk: "𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗡𝗲𝘂𝗿𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗳𝗼𝗿 𝗖𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗗𝗲𝘁𝗲𝗿𝗶𝗼𝗿𝗮𝘁𝗶𝗼𝗻", which we are particularly thrilled about. She will showcase Bitbrain's neuroscience research and discuss the use of neurotechnology in cognitive health. 📍 𝗩𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵, where Teresa will be waiting to welcome you. Experience firsthand how seamless our technology setup is and test out the reliability of our sensors in real-time! We are looking forward to engaging discussions and new synergies that will emerge from this congress and contributing to the growing field of brain health innovation. For a 𝘀𝗻𝗲𝗮𝗸 𝗽𝗲𝗲𝗸 𝗶𝗻𝘁𝗼 𝗼𝘂𝗿 𝗻𝗲𝘂𝗿𝗼𝘁𝗲𝗰𝗵 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀 and how they are advancing clinical practice and neuroscience research, visit our website: https://lnkd.in/djxYNxRZ . #MultiBrainII #Neurotech #BrainHealth #Neurotechnology #EEG

𝗠𝗮𝗿𝗸 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿!! 📅 Calling all researchers: EBRAINS congress on motor function circuits is coming in two weeks in Madrid! On November 28-29 we want to invite neuroscientists, researchers, and clinicians to the Aula Cajal at the Ilustre Colegio Oficial de Médicos de Madrid to discuss the most recent advances in motor function research. Find out all the incredible speakers that will join the session here below: https://lnkd.in/eZSCMcK8 This event offers attendees the chance to engage with EBRAINS’ advanced tools for studying brain circuits involved in motor function and dysfunction. Attendees will gain firsthand exposure to tools designed to enhance the study of brain circuits involved in movement, dysfunction, and rehabilitation, fostering discussions that could shape the future of neuroscience. Whether you’re focused on motor function, computational modeling, or the pathological brain, this event is a unique opportunity to connect, learn, and collaborate with peers from across the globe. Don’t miss out!! 📅 Date: November 28-29 📍 Location: Ilustre Colegio Oficial de Médicos Aula Cajal, Madrid 🔗 Register now to secure your place: https://lnkd.in/d6Qm5Civ

We are pleased to announce Bitbrain’s participation at MEDICA - Leading International Trade Fair 2024 in Düsseldorf. As a company at the forefront of neurotechnology, we are showcasing our 𝘄𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗘𝗘𝗚 𝗱𝗲𝘃𝗶𝗰𝗲𝘀, designed to meet the strictest medical standards. Our innovative 𝗜𝗸𝗼𝗻 𝗦𝗹𝗲𝗲𝗽 𝗱𝗲𝘃𝗶𝗰𝗲, a textile-based EEG solution, is expecting 𝗙𝗗𝗔 𝗮𝗻𝗱 𝗖𝗘 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 by 2025 and is developed and designed following medical regulations. This wearable device will play a key role in improving sleep monitoring, cognitive assessment, and digital health solutions. But we are not stopping there, Bitbrain is also progressing toward FDA and CE medical approval in the development of the Elevvo Neurohealth Platform, a home-based digital health solution that allows the performance of 𝗲𝗹𝗲𝗰𝘁𝗿𝗼𝗲𝗻𝗰𝗲𝗽𝗵𝗮𝗹𝗼𝗴𝗿𝗮𝗽𝗵𝘆 (EEG) and simplified 𝗽𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆 (PSG) tests at patients’ homes. Our aim is to make neurotechnology more accessible for patients and healthcare professionals. We are dedicated to advancing 𝗵𝘂𝗺𝗮𝗻-𝗰𝗲𝗻𝘁𝗿𝗲𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, ensuring that our technologies improve lives while adhering to the highest quality standards. The future of medical technology is 𝗲𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗿𝗮𝗽𝗶𝗱𝗹𝘆, and we are proud to be part of this transformative journey. Our team is waiting for all of you at 𝗯𝗼𝗼𝘁𝗵 𝗕𝟯𝟬-𝟰 𝗶𝗻 𝗛𝗮𝗹𝗹 𝟭𝟰!! Come find us to demo our products!! Ikon Sleep: https://lnkd.in/drArkVgJ Elevvo: https://lnkd.in/dxJQUS9G #MEDICA2024 #Neurotechnology #EEG #MedicalDevices #Medtech

Bitbrain’s journey in neurotechnology takes another step forward with our participation in the 𝟲𝘁𝗵 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗼𝗻 𝗡𝗲𝘂𝗿𝗼𝗥𝗲𝗵𝗮𝗯𝗶𝗹𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Held in 𝗟𝗮 𝗚𝗿𝗮𝗻𝗷𝗮, 𝗦𝗽𝗮𝗶𝗻, this conference is a convergence point for experts from Clinical Rehabilitation, Neurophysiology, and Biomedical Engineering, fostering collaboration on wearable robotics and therapeutic technologies. The topic is of considerable interest to us as we keep evolving in the topic and are internally investigating with our 𝗛𝗲𝗿𝗼 𝗘𝗘𝗚 device that provides high-quality data while ensuring ease of use and comfort for 𝗯𝗼𝘁𝗵 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀 𝗮𝗻𝗱 𝘂𝘀𝗲𝗿𝘀. The Hero is a robust mechanical design with nine targeted electrodes that enable 𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝗱 𝘀𝗲𝗻𝘀𝗼𝗿𝗶𝗺𝗼𝘁𝗼𝗿 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗶𝗻 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 settings, maintaining reliable data even during movement. Developed to be a user-friendly EEG system, it can be applied in 𝘂𝗻𝗱𝗲𝗿 𝘁𝘄𝗼 𝗺𝗶𝗻𝘂𝘁𝗲𝘀 𝗮𝗻𝗱 𝘄𝗶𝘁𝗵 𝗼𝗻𝗹𝘆 𝗼𝗻𝗲 𝗵𝗮𝗻𝗱 as shown in this video https://lnkd.in/eFbdMEpK More information about 𝗛𝗲𝗿𝗼 𝗘𝗘𝗚 https://lnkd.in/dp7N99CW Additionally, we will showcase our extensive range of 𝗵𝗶𝗴𝗵-𝘁𝗲𝗰𝗵 𝗘𝗘𝗚 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 for neuroscience research in and out of the lab. From our reliable dry and water-based sensor technologies to advanced biosignal detection systems, and of course our 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝘁𝗲𝘅𝘁𝗶𝗹𝗲 𝗘𝗘𝗚 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀: the Ikon and Ikon Sleep headband, designed to enhance research by enabling investigations in patients' homes. Our team is prepared to contribute to in-depth discussions at #ICNR2024 and hopes to forge new connections with fellow experts, exploring collaborative opportunities to 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗻𝗲𝘂𝗿𝗼𝗿𝗲𝗵𝗮𝗯𝗶𝗹𝗶𝘁𝗮𝘁𝗶𝗼𝗻 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀'effectiveness. We invite everyone to 𝗰𝗼𝗺𝗲 𝗳𝗶𝗻𝗱 𝘂𝘀 𝗮𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵 𝗦𝟰 (𝗳𝗹𝗼𝗼𝗿 –𝟭) to see our technology in action! #ICNR2024 #NeuroRehab #WearableNeurotech #BrainTech #EEG

¿Te apasiona la neurotecnología y la fabricación mecánica? 🧠 En Bitbrain tenemos una oportunidad laboral para ti. Si tienes formación de grado medio o superior en fabricación mecánica y te gustaría formar parte de una empresa innovadora en el campo de la neurotecnología, no dudes en echarle un vistazo a nuestra oferta. ¡Te estamos esperando! 🚀

As #CTAD24 comes to a close, we want to express our gratitude to everyone who contributed to the success of this conference. We had the opportunity to present our 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 aimed at treating 𝗮𝗺𝗻𝗲𝘀𝘁𝗶𝗰 𝗺𝗶𝗹𝗱 𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗶𝗺𝗽𝗮𝗶𝗿𝗺𝗲𝗻𝘁 (𝗲𝗮𝗿𝗹𝘆-𝘀𝘁𝗮𝗴𝗲 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀) using innovative neurotechnology designed for 𝗵𝗼𝗺𝗲 𝘂𝘀𝗲. The posters are available here -> https://lnkd.in/dGAezbsy The 𝗘𝘀𝗽𝗲𝗿𝗮𝗻𝘇𝗮 study investigates upper alpha neurofeedback for 𝗻𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 treatment in individuals with amnestic mild cognitive impairment (MCI), the 𝗡𝗮𝗻𝗮 research explores 𝗮𝘂𝗱𝗶𝘁𝗼𝗿𝘆 𝘀𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗱𝘂𝗿𝗶𝗻𝗴 𝘀𝗹𝗲𝗲𝗽 as a symptomatic treatment for amnestic MCI, and the 𝗛𝗼𝗴𝗮𝗿 study implements 𝗵𝗼𝗺𝗲-𝗯𝗮𝘀𝗲𝗱 𝗯𝗿𝗮𝗶𝗻 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 using a self-managed EEG to study cognitive decline in aging. Through stimulating conversations about Alzheimer's 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝘁𝗿𝗶𝗮𝗹𝘀 𝗮𝗻𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀, we have had rewarding experience over the last four days, learning greatly from other professionals. We explored 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘁𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀 with each session providing new viewpoints and gathering useful information that will 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗕𝗶𝘁𝗯𝗿𝗮𝗶𝗻 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵. We depart from Madrid with fresh insights and focused on our further efforts. Many thanks to the organizers, speakers, and participants for your 𝗱𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝘁𝗵𝗶𝘀 𝘃𝗶𝘁𝗮𝗹 𝗰𝗮𝘂𝘀𝗲. We look forward to continuing our ongoing investigations on cognitive deterioration. #Alzheimer #Neuroscience #Research #EEG

Our team is participating in the 17th Clinical Trials on Alzheimer's Disease ( CTAD Alzheimer ) conference in Madrid, Spain, from 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟵 𝘁𝗼 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭, 𝟮𝟬𝟮𝟰. Bitbrain’s researchers are presenting our research progress in our 𝟯 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝘁𝗼 𝗳𝗶𝗴𝗵𝘁 𝘁𝗵𝗶𝘀 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻. This conference focuses on 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝘁𝗿𝗶𝗮𝗹𝘀, gathering key researchers and industry leaders dedicated to the urgent mission of accelerating effective treatment development. Our presence at this event aligns with our ongoing commitment to 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗮𝗻𝗱 𝗮𝗱𝗱𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗱𝗲𝘁𝗲𝗿𝗶𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀. Attending #CTAD24 will provide us with a valuable opportunity to engage in meaningful discussions, exchange knowledge, and engage with fellow 𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁𝘀 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲. We look forward to fostering new connections and advancing the dialogue around 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁. For more technical information related to our research 𝗵𝗮𝘃𝗲 𝗮 𝗹𝗼𝗼𝗸 𝗮𝘁 𝗼𝘂𝗿 𝗽𝗼𝘀𝘁𝗲𝗿𝘀: 1. The 𝗘𝗦𝗣𝗘𝗥𝗔𝗡𝗭𝗔 study: 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 using upper alpha neurofeedback for amnestic mild cognitive impairment 2. The 𝗡𝗔𝗡𝗔 study: 𝗔𝘂𝗱𝗶𝘁𝗼𝗿𝘆 𝘀𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗱𝘂𝗿𝗶𝗻𝗴 𝘀𝗹𝗲𝗲𝗽 as symptomatic treatment for amnestic mild cognitive impairment 3. The 𝗛𝗼𝗴𝗮𝗿 𝘀𝘁𝘂𝗱𝘆: 𝗛𝗼𝗺𝗲-𝗯𝗮𝘀𝗲𝗱 𝗯𝗿𝗮𝗶𝗻 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 with a self-managed EEG to study cognitive decline in the aging population #Alzheimer #Neuroscience #Research

𝗗𝗼 𝘆𝗼𝘂 𝘀𝘁𝗶𝗹𝗹 𝘁𝗵𝗶𝗻𝗸 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗘𝗘𝗚 𝗰𝗮𝗻’𝘁 𝗯𝗲 𝘄𝗲𝗮𝗿𝗮𝗯𝗹𝗲, 𝗰𝗼𝗺𝗳𝗼𝗿𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗿𝗲𝗹𝗶𝗮𝗯𝗹𝗲 𝗮𝘁 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝘁𝗶𝗺𝗲!? We want to share with the scientific community the first open-access dataset that uses 𝘁𝗲𝘅𝘁𝗶𝗹𝗲-𝗯𝗮𝘀𝗲𝗱 𝗘𝗘𝗚 and accurately measures 𝗯𝗿𝗮𝗶𝗻 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆. 🧠👕 https://lnkd.in/dsgrbxvD Last year, our researchers conducted a study that demonstrates Ikon headband reliability in measuring brain activity, showing comparable performance to traditional systems while prioritizing user comfort. The study emphasizes that the 𝘁𝗲𝘅𝘁𝗶𝗹𝗲-𝗯𝗮𝘀𝗲𝗱 𝗘𝗘𝗚 (Bitbrain Ikon headband) represents a significant step toward making EEG technology more accessible and comfortable for the general population. By reducing manufacturing costs and enhancing usability, this technology could facilitate large-scale recordings for both clinical and non-clinical applications. The potential applications are vast—from clinical assessments to everyday brain health monitoring. We believe this technology can significantly improve access to EEG measurements, enhancing mental health and well-being. Please have a more detailed look at the 𝗳𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/ekpccnmh 𝗜𝗸𝗼𝗻 𝗛𝗲𝗮𝗱𝗯𝗮𝗻𝗱: https://lnkd.in/epcncFbD #Neurotech #Innovation #EEG #SmartTextiles

Metric
Company Name	Bitbrain	BrainCo	MetaBrain
Symbol
MSH ID	COM:BITBRAIN	CN:BRAINCO	NL:METABRAIN
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Neurotechnology	Medical Devices	Genomics
Country	ES	CN	NL
Stage		Seed
Employee Count
Website	bitbrain.com/en	brainco.cn	metabrain.nl
LinkedIn	bitbrain-technologies	brainco	metabrainlabs
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	4.67K
Web Traffic Growth	0.42
Valuation
Raised Capital	5.50M	11.48M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BITB

COM:BITBRAIN

Bitbrain

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue